Stockscreener 앱 받기
23.56
0.26%
0.06
전일 마감가:
$23.50
열려 있는:
$23.75
하루 거래량:
585.80K
Relative Volume:
0.80
시가총액:
$12.54B
수익:
$22.44B
순이익/손실:
$1.35B
주가수익비율:
12.40
EPS:
1.9002
순현금흐름:
$2.03B
1주 성능:
-1.30%
1개월 성능:
-2.28%
6개월 성능:
-1.87%
1년 성능:
-5.15%
1일 변동 폭
$23.55
$23.89
1주일 범위
$23.50
$23.94
52주 변동 폭
$20.02
$27.64
프레제니우스메디칼케어 Stock (FMS) Company Profile
Compare FMS vs HCA, THC, EHC, DVA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
23.56 | 12.51B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
411.73 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
270.21 | 21.30B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
122.10 | 12.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
177.91 | 11.27B | 13.84B | 1.10B | 1.49B | 10.42 |
프레제니우스메디칼케어 Stock (FMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-10-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2025-09-02 | 다운그레이드 | UBS | Neutral → Sell |
| 2024-12-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-11-06 | 개시 | Berenberg | Buy |
| 2024-01-08 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-17 | 업그레이드 | Societe Generale | Hold → Buy |
| 2023-08-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 재개 | Citigroup | Neutral |
| 2023-07-12 | 개시 | Goldman | Buy |
| 2023-03-07 | 개시 | Bernstein | Mkt Perform |
| 2023-01-03 | 다운그레이드 | Jefferies | Buy → Underperform |
| 2022-10-26 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-10-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-06-27 | 업그레이드 | Jefferies | Underperform → Buy |
| 2022-02-11 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2021-11-23 | 개시 | HSBC Securities | Hold |
| 2021-11-11 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-02-04 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2020-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-05-20 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-06-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-10 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | 업그레이드 | UBS | Neutral → Buy |
| 2018-08-28 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2018-07-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | 업그레이드 | UBS | Sell → Neutral |
| 2017-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-07-08 | 업그레이드 | Jefferies | Underperform → Hold |
| 2016-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2015-08-13 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2015-07-31 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 재확인 | Feltl & Co. | Hold |
| 2013-01-14 | 업그레이드 | HSBC Securities | Neutral → Overweight |
모두보기
프레제니우스메디칼케어 주식(FMS)의 최신 뉴스
Fresenius Medical Care stock trades close to analyst fair value as investors weigh guidance and sect - AD HOC NEWS
Fresenius Medical Care (FMS) Edges Higher to $23.77, Holds Range Between Key Support and ResistanceAndrews Pitchfork - Vinanet
Fresenius Medical Care stock steadies around $23 as investors weigh recent buybacks and guidance - ad-hoc-news.de
Fresenius Medical Care stock holds steady near $24 as investors digest latest capital market update - ad-hoc-news.de
Fresenius Medical Care stock holds near $23 as investors weigh latest earnings - ad-hoc-news.de
Fresenius Medical Care AG (FMS) Stock Forecasts - Yahoo! Finance Canada
Weekly Recap: Q2 results & guidance reaffirmed and Cassie McLean named CEO - TradingView
Fresenius Medical Care (FMS) Advances to $24.10: Near-Term Support and Resistance in FocusMax Pain Level - Vinanet
Fresenius Medical Care Q2 2026 slides: margins soar despite volume pressure - Investing.com
Fresenius Medical Care plunges 9.6% as weak U.S. volumes overshadow Q2 beat - Investing.com
Earnings call transcript: Fresenius Medical Care beats Q2 2026 EPS, shares fall - Investing.com
Why is Fresenius Medical Care stock sliding today? - Investing.com
Fresenius Medical Care ADR earnings beat by $0.31, revenue was in line with estimates - Investing.com
Fresenius Medical Care's Margin Improvement Story Looks Merely Stalled, Not Over - Morningstar
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery - Barchart.com
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients - Fresenius Medical Care
Why is Fresenius Medical Care stock down today? - Investing.com
BNP Paribas Exane downgrades Fresenius Medical Care stock rating on dialysis volume concerns - Investing.com
Fresenius Medical Care launches analytics tool for kidney therapy By Investing.com - Investing.com South Africa
Fresenius Medical Care launches analytics tool for kidney therapy - Investing.com
Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy - Fresenius Medical Care
FMC stock steadies as Fresenius Medical Care keeps its U.S. listing - Ad-hoc-news.de
How home hemodialysis is redefining kidney care - Fresenius Medical Care
The 5008 CorDiax from Fresenius Medical Caredialyzers built for US clinics - ad-hoc-news.de
FMC Fresenius Medical Care, background on dialysis business and stock - Ad-hoc-news.de
ETFs Investing in Fresenius Medical Care AG Sponsored ADR Stocks - TradingView
FMEA Forecast — Price Target — Prediction for 2027 - TradingView
Fresenius Medical Care with a clear strategy focus, shares on NYSE and Xetra watch - ad-hoc-news.de
879529 Forecast — Price Target — Prediction for 2027 - TradingView
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate - Investing.com
Fresenius Medical Care with clear analyst view, shares tracked on Xetra and NYSE - AD HOC NEWS
Finding strength in change: George’s journey with dialysis - Fresenius Medical Care
Fresenius Medical Care Stock (DE0005785802): Shares trade near EUR 40.90 after a modest Xetra gain - AD HOC NEWS
Fresenius Medical Care Stock (DE0005785802): Quarterly earnings keep NYSE-listed shares in focus - AD HOC NEWS
Why Is Fresenius Medical Care Stock Trending Right Now - Kalkine Media
Fresenius Medical Care Stock (DE0005785802): Technical breakout to new 4-week high - AD HOC NEWS
Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model - Fresenius Medical Care
High-Volume Hemodiafiltration Remains the Benchmark for Survival Evidence in Dialysis - Fresenius Medical Care
Fresenius Medical Care stock (DE0005785802): dialysis specialist in focus after Q1 figures and new s - AD HOC NEWS
Fresenius Medical Care stock (DE0005785802): What investors are watching now - AD HOC NEWS
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis - Fresenius Medical Care
The Ogden Water Project: Community Conservation - Fresenius Medical Care
Fresenius Medical Care launches €600M share buyback tranche By Investing.com - Investing.com India
Fresenius Medical Care launches €600M share buyback tranche - Investing.com
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million - Fresenius Medical Care
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026 - Fresenius Medical Care
Fresenius Medical Care announces €1 billion share buyback program - Investing.com
Fresenius Medical Care announces €1 billion share buyback program By Investing.com - Investing.com India
FMSFresenius Medical Care AG ADR Stock Price and Quote - Finviz
Fresenius Medical Care at the 63rd ERA Congress - Fresenius Medical Care
프레제니우스메디칼케어 (FMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
1.17%
자본화:
|
볼륨(24시간):